BMPR2 and pulmonary arterial hypertension: Targeted delivery of adenoviral vector containing the BMPR II gene to pulmonary vascular endothelium in rodent PAH models resulted in substantially reduced severity of PAH, providing evidence for the rationale for gene therapy in the setting [18].